Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05584735 · ClinicalTrials.gov registry record
Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 46
- Enrollment target
NCT05584735 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 46 participants.
The verdict
NCT05584735 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This study will evaluate the effect of the microorganisms in the gut on how well the flu or COVID-19 vaccine works in people who have a weakened immune system due to inflammatory bowel disease. Participants can expect to be in the study for up to 65 days.
Interventions
- BIOLOGICAL COVID-19 vaccine
- BIOLOGICAL Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2025-03-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05584735
The ClinicalTrials.gov registry entry for NCT05584735 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which COVID-19 vaccine is the first listed.
NCT05584735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05584735 about?
NCT05584735 is a clinical study titled "Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine". This study will evaluate the effect of the microorganisms in the gut on how well the flu or COVID-19 vaccine works in people who have a weakened immune system due to inflammatory bowel disease. Participants can expect to be in the study for up to 65 days.
What is the current status of trial NCT05584735?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2023-11-03. Estimated completion is 2025-03-20.
What interventions are being tested in trial NCT05584735?
The interventions under investigation include: COVID-19 vaccine (BIOLOGICAL), Influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05584735?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.